CDTX vs NVR · rev $1.3M vs P/E 15, rev $10.52B
Cidara Therapeutics Inc (CDTX) versus NVR Inc (NVR) — a side-by-side from cached financials, not a winner call.
Cidara Therapeutics Inc (CDTX) is a biotechnology company listed on US.
NVR Inc (NVR) is a residential construction company listed on NYSE.
Latest reported CDTX revenue for 2024-12-31 was $1.3M. Net income was -$169.8M. Revenue was down 94.5% from 2023-12-31 to 2024-12-31. CDTX currently screens at market cap $6.96B.
Latest reported NVR revenue for 2024-12-31 was $10.52B. Net income was $1.68B. Revenue was up 10.6% from 2023-12-31 to 2024-12-31. NVR currently screens at market cap $16.94B and trailing P/E 15.3.
CDTX currently screens at market cap $6.96B. NVR currently screens at market cap $16.94B and trailing P/E 15.3.
Not investment advice. Open the CDTX and NVR stock pages for the full models.
Not investment advice.